Search：
All Dates (UTC+8)：
- All
- 2020-10-18 [Sunday]
- 2020-10-19 [Monday]
- 2020-10-20 [Tuesday]
- 2020-10-21 [Wednesday]
- 2020-10-22 [Thursday]
- 2020-10-23 [Friday]
- 2020-10-24 [Saturday]
- 2020-10-25 [Sunday]
Hall：
- All
- Closing Ceremony
- Hypertension Channel
- Clinical Coronary Artery Disease Channel
- Coronary Intervention Channel
- Cardiac Arrhythmia Channel
- Atrial Fibrillation Channel
- Heart Failure and Cardiomyopathy Channel
- Cardiac Emergency & Critical Disease Channel
- Interpretation of Clinical Research and Guideline Channel
- Meet the Experts
- Comprehensive Channel 1
- Comprehensive Channel 2
- Comprehensive Channel 3
- Cardiovascular Nursing Channel
- Tradional Chinese Medicine Channel
- Ability Enhancement of CVD Management Channel
- County Healthcare Channel
- International Cooperation Channel 1
- International Cooperation Channel 2
- Asia Cooperation Channel
- Prevention and Rehabilitation Channel
- Cardiovascular Imaging Channel
- Basic Research Channel
- Humanities Channel
- Professional Development of Young Physicians Channel
- Innovation, Development and Industry Channel
- Primary PCI Week
- Structure Week Channel
- PCI Optimization Channel
- Atrial Fibrillation Week Channel
- CTO Week Channel
- Training Workshop Channel
Forum：
- All
- Hypertension Forum
- Community and Rural Hypertension Forum
- Atherosclerosis and Coronary Artery Disease Forum
- Valvular Heart Disease Forum
- Metabolic and Cardiovascular Disease Forum
- Coronary Artery Disease and Atrial Fibrillation Forum
- Arterial Thrombotic Disease Forum
- Acute Coronary Syndrome Forum
- Chest Pain Forum
- Coronary Interventional Technique and Training Forum
- Coronary Physiology and Imaging Forum
- Coronary Intervention “Double Safety” Forum
- CHIP Forum
- CTO Forum
- PCI Optimization Forum
- Clinical Cardiac Arrhythmias Forum
- Ventricular Arrhythmias Forum
- Noninvasive Diagnosis Forum
- Cardiac Pacing and Device Therapy Forum
- Physiological Pacing Forum
- Atrial Fibrillation Forum
- Catheter Ablation of Atrial Fibrillation Forum
- Catheter Ablation of Atrial Fibrillation “Doubled Safety” Forum
- Heart Failure Forum
- Cardiomyopathy and Pericardial Disease Forum
- Pulmonary Vascular Disease
- Cardiac Emergency & Critical Disease Forum
- Extracorporeal Life Support Forum
- Primary PCI Week
- Cardiac Surgery Forum
- TAVI Forum
- Aortic and Peripheral Vascular Disease Forum
- Left Atrial Appendage Closure Forum
- Adult Congenital Heart Disease and PFO Forum
- Renal Artery Denervation and Autonomic Nervous Regulation Forum
- Cardiovascular Disease in Elderly Forum
- Cardiovascular Disease in Females Forum
- Pediatric Cardiovascular Disease Forum
- Maternal-Fetal Medicine Forum
- Safe Medication in Cardiovascular Disease Forum
- Inherited Cardiac Disease Forum
- Cardiovascular Laboratory Forum
- Stroke Forum
- Diabetes Mellitus Forum
- Sleep-Related Breathing Disorder and Cardiovascular Disease Forum
- Mental Health and Cardiovascular Disease Forum
- Cardiovascular Nursing Forum
- General Medicine Forum
- Traditional Chinese Medicine Channel
- Development of Country Cardiovascular Health Care Forum
- Medical Humanities Forum
- Professional Development of Young Physicians Forum
- Asian Heart Forum
- International Joint Forum
- Cardiovascular Rehabilitation Forum
- Cardiovascular Prevention Forum
- Ultrasound Forum
- CT Forum
- MRI Forum
- Nuclear Medicine Forum
- Basic Research Forum
- Clinical Research Training Forum
- Recent Clinical Research in China Forum
- Interpretation of Domestic and International Guidelines Forum
- Difficult and Complicated Cases Forum
- Cardiovascular Clinical Practice (Meet the Experts)-Hypertension
- Clinical Practice of Cardiology （Meet the Experts）- Coronary Artery Disease
- Clinical Practice of Cardiology （Meet the Experts）-Cardiac Arrhythmias
- Cardiovascular Innovation and Transformation Forum
- Cardiovascular Clinical Practice (Meet the Experts)-Heart Failure
- Cardio-Oncology Forum
- Cardiovascular Clinical Practice (Meet the Experts)-Cardiac Emergency & Critical Disease
- Artificial Intelligence Forum
- Internet Medicine Forum
- Big Data Forum
- Young Investigator Award
- Oral Presentation
- English Speech Competitions
- Closing Ceremony
Clinical Coronary Artery Disease Channel
2020-10-19 (UTC+8) Mon 2020-10-19 Local Time
09:00-10:30 (UTC+8)
09:00-10:30
Local Time | Basic Research of Coronary Artery Disease 【Atherosclerosis and Coronary Artery Disease Forum】 [Atherosclerosis and Coronary Artery Disease Forum]Slide：Chinese Language：Chinese
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 09:00-09:15 | 09:00-09:15 |
Role of Vascular Stem/ Progenitor Cells in Arteriosclerosis |
Qingbo Xu | The First Affiliated Hospital, Zhejiang University School of Medicine |
| 09:15-09:18 | 09:15-09:18 |
Discussion |
||
| 09:18-09:33 | 09:18-09:33 |
Diet and Cholesterol Metabolism |
Baoliang Song | Life Sciences, Wuhan University |
| 09:33-09:36 | 09:33-09:36 |
Discussion |
||
| 09:36-09:51 | 09:36-09:51 |
MiR-483-PCSK9 Pathway and Its Role in Atherosclerosis |
Zuyi Yuan | The First Affiliated Hospital of Xi ' An Jiaotong University |
| 09:51-09:54 | 09:51-09:54 |
Discussion |
||
| 09:54-10:09 | 09:54-10:09 |
Gene Editing Therapy for Familial Hypercholesterolemia |
Bin Zhou | Shanghai Institute of Nutrition and Health,Chinese Academy of Sciences |
| 10:09-10:12 | 10:09-10:12 |
Discussion |
||
| 10:12-10:27 | 10:12-10:27 |
Research on the Relationship Between Small Molecule Gas Mediated Protein Modification and Cardiovascular Disease |
Yong Ji | |
| 10:27-10:30 | 10:27-10:30 |
Discussion |
||
11:00-12:30 (UTC+8)
11:00-12:30
Local Time | 【Symposium】 Novartis Symposium: New Frontier of Lipid Management in ASCVD：Lp(a) and Novel Therapy 【Atherosclerosis and Coronary Artery Disease Forum】 [Atherosclerosis and Coronary Artery Disease Forum]Slide：Chinese Language：Chinese
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 11:00-11:15 | 11:00-11:15 |
Current Status and Residual Risk of Lipid Lowering Therapy for Secondary Prevention of Atherosclerosis Cardiovascular Disease |
Yihong Sun | China-Japan Friendship Hospital |
| 11:15-11:30 | 11:15-11:30 |
Current Knowledge of Mechanism of Lp(A) on ASCVD |
Jianjun Li | Fuwai Hospital, Chinese Academy of Medical Sciences |
| 11:30-11:45 | 11:30-11:45 |
New Clinical Evidence of Lp(A) and ASCVD |
Zhenyue Chen | Ruijin Hospital, Shanghai Jiaotong University School of Medicine |
| 11:45-12:00 | 11:45-12:00 |
Gene Therapy: a Novel Method of Lp(a) Targeted Therapy |
Ye Zhu | West China Hospital of Sichuan University |
| 12:00-12:30 | 12:00-12:30 |
Discussion: Are We Ready for the Era of LP (a) Targeted Therapy |
||
12:30-14:00 (UTC+8)
12:30-14:00
Local Time | Coronary Artery Disease Prevention 【Atherosclerosis and Coronary Artery Disease Forum】 [Atherosclerosis and Coronary Artery Disease Forum]Slide：Chinese Language：Chinese
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 12:30-12:45 | 12:30-12:45 |
Re-Discussion of Aspirin in Primary Prevention of Atherosclerotic Heart Disease |
Yulan Zhao | The Second Affiliated Hospital of Zhengzhou University |
| 12:45-13:00 | 12:45-13:00 |
Sex Differences in Primary and Secondary Prevention of Cardiovascular Disease in China |
Xin Du | |
| 13:00-13:15 | 13:00-13:15 |
Role of Oral Anticoagulants in the Primary and Secondary Prevention of Coronary Artery Disease |
Suxin Luo | The First Affiliated Hospital of Chongqing Medical University |
| 13:15-13:30 | 13:15-13:30 |
Primary Prevention Strategy for Coronary Artery Disease in Patients with Familial Hypercholesterolemia |
Xiangping Li | The Second Xiangya Hospital of Central South University |
| 13:30-13:45 | 13:30-13:45 |
Current Cardiovascular Risk Stratification: View from China-PAR Project |
fangchao liu | Fuwai Hospital |
| 13:45-14:00 | 13:45-14:00 |
Epidemiology and Current Status of Prevention and Treatment of Dyslipidemia Among Chinese Population |
Dong Zhao | Beijing Anzhen Hospital |
14:00-15:45 (UTC+8)
14:00-15:45
Local Time | Interventional Therapy for Coronary Artery Disease 【Atherosclerosis and Coronary Artery Disease Forum】 [Atherosclerosis and Coronary Artery Disease Forum]Slide：Chinese Language：Chinese
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 14:00-14:15 | 14:00-14:15 |
BVS: Progress and Considerations |
Yaling Han | General Hospital of Northern Theater Command |
| 14:15-14:30 | 14:15-14:30 |
Application of DCB in De-Novo Coronary Lesion |
Hongliang Cong | Tianjin Chest Hospital |
| 14:30-14:45 | 14:30-14:45 |
The Application of OCT in the Era of “Nothing Left” |
Bo Yu | The second affiliated hospital of harbin medical university |
| 14:45-15:00 | 14:45-15:00 |
“Nothing Left” – DCB: Data from Real-World |
Chunguang Qiu | The First Affiliated Hospital of Zhengzhou University |
| 15:00-15:15 | 15:00-15:15 |
ADR: Experience from the Chinese Interventionalist |
Chengxiang Li | Xijing Hospital of Air Force Medical University of PLA |
| 15:15-15:30 | 15:15-15:30 |
State-of-Art: CTO Interventional Therapy |
Jie Qian | Fuwai Hospital, Chinese Academy of Medical Sciences |
| 15:30-15:45 | 15:30-15:45 |
What Can We Learn from the ISCHEMIA Study |
Xiaogang Guo | The First Affiliated Hospital, Zhejiang University School of Medicine |
16:00-17:30 (UTC+8)
16:00-17:30
Local Time | 【Symposium】 Amgen Symposium【Atherosclerosis and Coronary Artery Disease Forum】 [Atherosclerosis and Coronary Artery Disease Forum]Slide：Chinese Language：Chinese
| Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 16:00-16:02 | 16:00-16:02 |
Opening |
||
| 16:02-16:22 | 16:02-16:22 |
ESC Spotlight: Focus on Lipid Management in AMI Patients |
Daoquan Peng | The Second Xiangya Hospital of Central South University |
| 16:22-16:42 | 16:22-16:42 |
From Plaque Regression to Extremely High-risk Patient’s Intensive Lipid-lowering Therapy |
Zhenyue Chen | Ruijin Hospital, Shanghai Jiaotong University School of Medicine |
| 16:42-17:02 | 16:42-17:02 |
PCSK9 Inhibitor Treatment in High-risk Patients with Complex Coronary Heart Disease |
Qianyun Guo | Fuwai Hospital |
| 17:02-17:22 | 17:02-17:22 |
Role of PCSK9 Inhibitor’s in Individual Treatment for Dyslipidemia |
li shen | The Second Xiangya Hospital of Central South University |
| 17:22-17:30 | 17:22-17:30 |
Discussion |
||